Torrent Pharmaceuticals Ltd (TORNTPHARM ፦ ) የአክሲዮን ዋጋ እና ዜና

(INR)	ማርች 2025	ከዓመት ዓመት ለውጥ
ገቢ	29.59 ቢ	7.80%
የሥራ ወጪ	14.65 ቢ	6.68%
የተጣራ ገቢ	4.98 ቢ	10.82%
የተጣራ የትርፍ ክልል	16.83	2.81%
ገቢ በሼር	15.24	14.85%
EBITDA	9.62 ቢ	9.23%
ውጤታማ የግብር ተመን	25.11%	—

ቀሪ ሒሳብ ሉሆች

አጠቃላይ ንብረቶች

አጠቃላይ ተጠያቂነቶች

(INR)	ማርች 2025	ከዓመት ዓመት ለውጥ
ጥሬ ገንዘብና የአጭር ጊዜ መዋዕለ ንዋይ	6.91 ቢ	-31.18%
አጠቃላይ ንብረቶች	149.90 ቢ	-0.47%
አጠቃላይ ተጠያቂነቶች	73.99 ቢ	-9.82%
አጠቃላይ እሴት	75.91 ቢ	—
የሼሮቹ ብዛት	338.55 ሚ	—
የገበያ ዋጋ እና የተገለጸ ዋጋ	14.37	—
የእሴቶች ተመላሽ	—	—
የካፒታል ተመላሽ	17.81%	—

የገንዘብ ፍሰት

የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ

(INR)	ማርች 2025	ከዓመት ዓመት ለውጥ
የተጣራ ገቢ	4.98 ቢ	10.82%
ከክወናዎች የተገኘ ጥሬ ገንዘብ	—	—
ገንዘብ ከኢንቨስትመንት	—	—
ገንዘብ ከፋይናንስ	—	—
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ	—	—
ነፃ የገንዘብ ፍሰት	—	—

ስለ

Torrent Pharmaceuticals Ltd, d/b/a Torrent Pharma is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd. Torrent Pharmaceuticals operates in more than 40 countries with over 2,000 product registrations globally. Torrent Pharma is active in the therapeutic areas of cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. It also has a presence in therapeutic segments of nephrology, oncology, gynecology, respiratory and pediatrics. Wikipedia

የተመሰረተው

1959

ዋና መሥሪያ ቤት

አህመድኣባድ፣ ጉጀራት
ህንድ

ድህረገፅ

torrentpharma.com

ሠራተኞች

15,718